Alzheimer's disease patients institutionalized in group homes run by long‐term care insurance exhibit fewer symptoms of behavioural problems as evaluated by the Behavioural Pathology in Alzheimer's Disease Rating Scale

Publisher： John Wiley & Sons Inc

E-ISSN： 1479-8301|15|2|102-108

ISSN： 1346-3500

Source： Psychogeriatrics, Vol.15, Iss.2, 2015-06, pp. : 102-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gabapentin appears to improve behavioural alterations in patients with probable Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Effects of Cholinesterase Inhibitors on Behavioural Disturbances in Alzheimer's Disease: A Systematic Review

By Grimmer Timo   Kurz Alexander  

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 957-967

Adis International

Access to resources Recommend Favorite

A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease

By Wilcock G.  

Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. : 777-789

Adis International

Access to resources Recommend Favorite

Long-Term Cholinesterase Inhibitor Treatment of Alzheimer’s Disease

By Peter Johannsen  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 757-768

Adis International

Access to resources Recommend Favorite

Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimer's Disease: An Open-Label Pilot Study

By Herrmann Nathan   Cappell Jaclyn  

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 425-433

Adis International

Access to resources Recommend Favorite